Apoptosis is triggered when prosurvival Bcl-2 proteins cannot restrain Bax

被引:156
作者
Fletchera, Jamie I. [1 ]
Meusburger, Sarina [1 ]
Hawkins, Christine J. [2 ]
Riglar, David T. [1 ]
Lee, Erinna F. [1 ]
Fairlie, W. Douglas [1 ]
Huang, David C. S. [1 ]
Adams, Jerry M. [1 ]
机构
[1] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia
[2] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia
基金
英国医学研究理事会;
关键词
BH3; domain; control of apoptosis; mitochondria; protein association; membrane association;
D O I
10.1073/pnas.0808691105
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A central issue in the control of apoptosis is whether its essential mediators Bax and Bak must be restrained by Bcl-2-like prosurvival relatives to prevent their damaging mitochondria and unleashing apoptosis. The issue is particularly vexed for Bax, which is largely a cytosolic monomer in unstressed cells. To determine whether Bax regulation requires its binding by prosurvival relatives, we replaced a conserved aspartate in its BH3 interaction domain with arginine. Bax D68R functioned and behaved like wild-type Bax in localization and activation but had greatly impaired binding to the prosurvival family members. Nevertheless, Bcl-x(L) remained able to block apoptosis induced by Bax D68R. Whereas cells with sufficient Bcl-x(L) tolerated expression of Bax D68R, it provoked apoptosis when Bcl-x(L) was absent, downregulated, or inactivated. Moreover, Bax D68R rendered membrane bound by a C-terminal anchor mutation overwhelmed endogenous Bcl-x(L) and killed cells. These unexpected results suggest that engagement of Bax by its prosurvival relatives is a major barrier to its full activation. We propose that the Bcl-2-like proteins must capture the small proportion of Bax molecules with an exposed BH3 domain, probably on the mitochondrial membrane, to prevent Bax-imposed cell death, but that Bcl-x(L) also controls Bax by other mechanisms.
引用
收藏
页码:18081 / 18087
页数:7
相关论文
共 51 条
  • [1] The Bcl-2 apoptotic switch in cancer development and therapy
    Adams, J. M.
    Cory, S.
    [J]. ONCOGENE, 2007, 26 (09) : 1324 - 1337
  • [2] Bcl-XL inhibits membrane permeabilization by competing with Bax
    Billen, Lieven P.
    Kokoski, Candis L.
    Lovell, Jonathan F.
    Leber, Brian
    Andrews, David W.
    [J]. PLOS BIOLOGY, 2008, 6 (06): : 1268 - 1280
  • [3] Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist bim
    Bouillet, P
    Cory, S
    Zhang, LC
    Strasser, A
    Adams, JM
    [J]. DEVELOPMENTAL CELL, 2001, 1 (05) : 645 - 653
  • [4] Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function
    Chen, L
    Willis, SN
    Wei, A
    Smith, BJ
    Fletcher, JI
    Hinds, MG
    Colman, PM
    Day, CL
    Adams, JM
    Huang, DCS
    [J]. MOLECULAR CELL, 2005, 17 (03) : 393 - 403
  • [5] Bax-independent inhibition of apoptosis by Bcl-x(L)
    Cheng, EHY
    Levine, B
    Boise, LH
    Thompson, CB
    Hardwick, JM
    [J]. NATURE, 1996, 379 (6565) : 554 - 556
  • [6] A CONSERVED DOMAIN IN BAK, DISTINCT FROM BH1 AND BH2, MEDIATES CELL-DEATH AND PROTEIN-BINDING FUNCTIONS
    CHITTENDEN, T
    FLEMINGTON, C
    HOUGHTON, AB
    EBB, RG
    GALLO, GJ
    ELANGOVAN, B
    CHINNADURAI, G
    LUTZ, RJ
    [J]. EMBO JOURNAL, 1995, 14 (22) : 5589 - 5596
  • [7] DeLano W. L., 2002, PYMOL
  • [8] Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells
    Dewson, G
    Snowden, RT
    Almond, JB
    Dyer, MJS
    Cohen, GM
    [J]. ONCOGENE, 2003, 22 (17) : 2643 - 2654
  • [9] To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3: Groove interactions
    Dewson, Grant
    Kratina, Tobias
    Sim, Huiyan W.
    Puthalakath, Hamsa
    Adams, Jerry M.
    Colman, Peter M.
    Kluck, Ruth M.
    [J]. MOLECULAR CELL, 2008, 30 (03) : 369 - 380
  • [10] Probing tumor phenotypes using stable and regulated synthetic microRNA precursors
    Dickins, RA
    Hemann, MT
    Zilfou, JT
    Simpson, DR
    Ibarra, I
    Hannon, GJ
    Lowe, SW
    [J]. NATURE GENETICS, 2005, 37 (11) : 1289 - 1295